212 related articles for article (PubMed ID: 22404448)
1. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Gisbert JP; McNicholl AG
Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
[No Abstract] [Full Text] [Related]
2. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
Sasaki M; Ogasawara N; Utsumi K; Kamiya T; Kataoka H; Tanida S; Mizoshita T; Shimura T; Hirata Y; Kasugai K; Joh T
Methods Find Exp Clin Pharmacol; 2010 May; 32(4):243-6. PubMed ID: 20508872
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
[No Abstract] [Full Text] [Related]
6. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
[TBL] [Abstract][Full Text] [Related]
7. Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
Frem JC; Gold BD; Shehata BM; Cole CR
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):589-92. PubMed ID: 18493216
[No Abstract] [Full Text] [Related]
8. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
Sánchez-Delgado J
Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
[No Abstract] [Full Text] [Related]
9. Guidelines for treatment of Helicobacter pylori in the East and West.
Selgrad M; Bornschein J; Malfertheiner P
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):581-8. PubMed ID: 21819326
[TBL] [Abstract][Full Text] [Related]
10. Predicting Helicobacter pylori eradication: how to teach an old dog new tricks!
Zullo A; De Francesco V; Hassan C
J Clin Gastroenterol; 2012 Apr; 46(4):259-61. PubMed ID: 22395061
[No Abstract] [Full Text] [Related]
11. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
13. H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
Zullo A; Cristofari F; Hassan C
Dig Liver Dis; 2009 Feb; 41(2):141-2. PubMed ID: 19112053
[No Abstract] [Full Text] [Related]
14. Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Fagoonee S; Astegiano M; Smedile A; Pellicano R
Panminerva Med; 2013 Sep; 55(3):309-10. PubMed ID: 24088806
[No Abstract] [Full Text] [Related]
15. [Eradication therapy for Helicobacter pylori infection: review of world trends].
Maev IV; Kucheriavyĭ IuA; Andreev DN; Barkalova EV
Ter Arkh; 2014; 86(3):94-9. PubMed ID: 24779078
[TBL] [Abstract][Full Text] [Related]
16. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
Cai W; Zhou L; Ren W; Deng L; Yu M
Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
[TBL] [Abstract][Full Text] [Related]
17. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
18. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
[TBL] [Abstract][Full Text] [Related]
19. [Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)].
Molina-Infante J; Gisbert JP
Gastroenterol Hepatol; 2013; 36(6):375-81. PubMed ID: 23623461
[TBL] [Abstract][Full Text] [Related]
20. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Iwasaki A
Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
